Literature DB >> 22890501

Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia.

Davide Martino1, Alfredo Berardelli, Giovanni Abbruzzese, Anna Rita Bentivoglio, Marcello Esposito, Giovanni Fabbrini, Arianna Guidubaldi, Paolo Girlanda, Rocco Liguori, Lucio Marinelli, Francesca Morgante, Lucio Santoro, Giovanni Defazio.   

Abstract

BACKGROUND: The site of dystonia onset is known to affect the risk of spread in primary adult-onset focal dystonia, but other factors possibly influencing spread are unknown. This study explored the relationship between age and spread of dystonia in primary adult-onset focal dystonia.
METHODS: Two survival models analyzed spread of dystonia in a large cohort of patients with primary blepharospasm (BSP) and cervical dystonia. The first model was based on time interval between onset and spread of dystonia, and the second model was based on age at spread.
RESULTS: Patients presenting with BSP had a 2-fold higher rate of spread than those presenting with cervical dystonia, regardless of the survival model used. However, survival analysis, based on age at spread, showed that spread develops at a similar age period in both groups, with most spread events occurring after the age of 50.
CONCLUSIONS: The convergent age of spread in BSP and cervical dystonia is a novel finding indicating age as a factor modulating spread of dystonia. These findings may assist in informing prognostication for patients with primary adult-onset focal dystonia.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 22890501     DOI: 10.1002/mds.25088

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

Review 1.  Designing clinical trials for dystonia.

Authors:  Wendy R Galpern; Christopher S Coffey; Alberto Albanese; Ken Cheung; Cynthia L Comella; Dixie J Ecklund; Stanley Fahn; Joseph Jankovic; Karl Kieburtz; Anthony E Lang; Michael P McDermott; Jeremy M Shefner; Jan K Teller; John L P Thompson; Sharon D Yeatts; H A Jinnah
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 2.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

Review 3.  Medical and Surgical Treatments for Dystonia.

Authors:  H A Jinnah
Journal:  Neurol Clin       Date:  2020-03-02       Impact factor: 3.806

Review 4.  Psychogenic movement disorders.

Authors:  Francesca Morgante; Mark J Edwards; Alberto J Espay
Journal:  Continuum (Minneap Minn)       Date:  2013-10

5.  Clinical and demographic characteristics related to onset site and spread of cervical dystonia.

Authors:  Scott A Norris; H A Jinnah; Alberto J Espay; Christine Klein; Norbert Brüggemann; Richard L Barbano; Irene Andonia C Malaty; Ramon L Rodriguez; Marie Vidailhet; Emmanuel Roze; Stephen G Reich; Brian D Berman; Mark S LeDoux; Sarah Pirio Richardson; Pinky Agarwal; Zoltan Mari; William G Ondo; Ludy C Shih; Susan H Fox; Alfredo Berardelli; Claudia M Testa; Florence Ching-Fen Cheng; Daniel Truong; Fatta B Nahab; Tao Xie; Mark Hallett; Ami R Rosen; Laura J Wright; Joel S Perlmutter
Journal:  Mov Disord       Date:  2016-10-18       Impact factor: 10.338

Review 6.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

7.  Blepharospasm in a multiplex African-American pedigree.

Authors:  Jianfeng Xiao; Misty M Thompson; Satya R Vemula; Mark S LeDoux
Journal:  J Neurol Sci       Date:  2016-02-02       Impact factor: 3.181

8.  Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes.

Authors:  H A Jinnah; Emily Goodmann; Ami R Rosen; Marian Evatt; Alan Freeman; Stewart Factor
Journal:  J Neurol       Date:  2016-04-25       Impact factor: 4.849

9.  The Use of Botulinum Toxin for Treatment of the Dystonias.

Authors:  Alfredo Berardelli; Antonella Conte
Journal:  Handb Exp Pharmacol       Date:  2021

10.  Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusion.

Authors:  Meng Wang; Tolulope Sajobi; Francesca Morgante; Charles Adler; Pinky Agarwal; Tobias Bäumer; Alfredo Berardelli; Brian D Berman; Joel Blumin; Max Borsche; Allison Brashear; Andres Deik; Kevin Duque; Alberto J Espay; Gina Ferrazzano; Jeanne Feuerstein; Susan Fox; Samuel Frank; Mark Hallett; Joseph Jankovic; Mark S LeDoux; Julie Leegwater-Kim; Abhimanyu Mahajan; Irene A Malaty; William Ondo; Alexander Pantelyat; Sarah Pirio-Richardson; Emmanuel Roze; Rachel Saunders-Pullman; Oksana Suchowersky; Daniel Truong; Marie Vidailhet; Aparna Wagle Shukla; Joel S Perlmutter; Hyder A Jinnah; Davide Martino
Journal:  Eur J Neurol       Date:  2021-08-04       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.